MicroRNAs in heart failure: Non-coding regulators of metabolic function

- Heart failure-related miRNA profiling in myocardium: miRNA signature and dynamic changes during disease progression
- Circulating miRNAs as biomarkers in heart failure: properties, signature and limitations
- MiRNAs in metabolic homeostasis: glucose, fatty acid, lipid and energy metabolism
- Sirtuins mediate deacetylation and are controlled by miRNAs.
- MiRNA therapy: miRNA silencing and miRNA overexpression

Heart failure (HF) is the inability of the heart to provide sufficient cardiac output for the energy demands of the body. Over the last decades, our understanding of the role of microRNAs (miRNAs), a class of small non-coding RNA regulators of gene expression at the post-transcriptional level, in cardiovascular diseases has expanded at a rapid rate. Importantly, multiple miRNAs have been specifically implicated in the progression of HF. Growing evidence suggests that miRNAs regulate central metabolic pathways and thus are highly implicated in the maintenance of energy homeostasis. In this review, we highlight recent discoveries of the mechanistic role of miRNAs in regulating metabolic functions in HF, with specific focus on the implication of miRNAs in metabolic rearrangements, discuss the potential value of miRNA profiles as novel HF biomarkers, and summarize the recent investigations on therapeutic approaches using miRNAs in heart disease. This article is part of a Special Issue entitled: The role of post-translational protein modifications on heart and vascular metabolism edited by Jason R.B. Dyck & Jan F.C. Glatz.